After being diagnosed with right breast invasive ductal carcinoma (stage III, HER2-positive), neoadjuvant chemotherapy was initiated (AC regimen: liposomal doxorubicin + cyclophosphamide). This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.